Do analysts rate FEED or LFWD?

Lifeward has a consensus target price of $10.00, suggesting a potential upside of 43.64%. Given Lifeward's stronger consensus rating and higher possible upside, analysts clearly believe Lifeward is more favorable than Nanovibronix. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanovibronix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lifeward 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Is FEED or LFWD more profitable?

Lifeward has a net margin of -123.66% compared to Nanovibronix's net margin of -923.20%. Nanovibronix's return on equity of -54.25% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Nanovibronix -923.20% -54.25% -43.10% Lifeward -123.66% -243.14% -97.39%

Does the media prefer FEED or LFWD?

In the previous week, Nanovibronix had 1 more articles in the media than Lifeward. MarketBeat recorded 3 mentions for Nanovibronix and 2 mentions for Lifeward. Lifeward's average media sentiment score of 1.33 beat Nanovibronix's score of 0.96 indicating that Lifeward is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nanovibronix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lifeward 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate IRIX or FEED?

IRIDEX currently has a consensus price target of $3.00, indicating a potential upside of 157.73%. Given IRIDEX's stronger consensus rating and higher probable upside, equities research analysts clearly believe IRIDEX is more favorable than Nanovibronix. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nanovibronix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, IRIX or FEED?

IRIDEX has higher revenue and earnings than Nanovibronix. IRIDEX is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.38 -$4.44M -$0.19 N/A Nanovibronix $2.18M 2.30 -$18.18M -$8.82 N/A

Is IRIX or FEED more profitable?

IRIDEX has a net margin of -6.23% compared to Nanovibronix's net margin of -923.20%. Nanovibronix's return on equity of -54.25% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% -1,204.74% -11.16% Nanovibronix -923.20% -54.25% -43.10%

Does the media refer more to IRIX or FEED?

In the previous week, IRIDEX and IRIDEX both had 3 articles in the media. Nanovibronix's average media sentiment score of 0.96 beat IRIDEX's score of 0.87 indicating that Nanovibronix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nanovibronix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer FEED or RVP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanovibronix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate FEED or HIND?

Vyome has a consensus price target of $15.00, suggesting a potential upside of 563.72%. Given Vyome's stronger consensus rating and higher probable upside, analysts clearly believe Vyome is more favorable than Nanovibronix. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanovibronix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has stronger earnings and valuation, FEED or HIND?

Vyome has lower revenue, but higher earnings than Nanovibronix. Vyome is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nanovibronix $2.18M 2.30 -$18.18M -$8.82 N/A Vyome $152.72K 103.85 -$10.26M -$12.27 N/A

Is FEED or HIND more profitable?

Vyome has a net margin of -270.58% compared to Nanovibronix's net margin of -923.20%. Nanovibronix's return on equity of -54.25% beat Vyome's return on equity. Company Net Margins Return on Equity Return on Assets Nanovibronix -923.20% -54.25% -43.10% Vyome -270.58% -203.92% -134.16%

Does the media prefer FEED or HIND?

In the previous week, Nanovibronix and Nanovibronix both had 3 articles in the media. Vyome's average media sentiment score of 1.28 beat Nanovibronix's score of 0.96 indicating that Vyome is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nanovibronix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vyome 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer OSRH or FEED?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nanovibronix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is OSRH or FEED more profitable?

OSR has a net margin of -363.26% compared to Nanovibronix's net margin of -923.20%. OSR's return on equity of -7.24% beat Nanovibronix's return on equity. Company Net Margins Return on Equity Return on Assets OSR -363.26% -7.24% -5.41% Nanovibronix -923.20% -54.25% -43.10%

Does the media favor OSRH or FEED?

In the previous week, Nanovibronix had 1 more articles in the media than OSR. MarketBeat recorded 3 mentions for Nanovibronix and 2 mentions for OSR. Nanovibronix's average media sentiment score of 0.96 beat OSR's score of 0.93 indicating that Nanovibronix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OSR 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nanovibronix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Nanovibronix (FEED) Competitors

$0.82 -0.01 (-1.11%)

As of 03:02 PM Eastern

Compare

FEED vs. LFWD, IRIX, RVP, HIND, and OSRH

Should you buy Nanovibronix stock or one of its competitors? MarketBeat compares Nanovibronix with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nanovibronix include Lifeward (LFWD), IRIDEX (IRIX), Retractable Technologies (RVP), Vyome (HIND), and OSR (OSRH). These companies are all part of the "medical equipment" industry.

How does Nanovibronix compare to Lifeward?

Nanovibronix (NASDAQ:FEED) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 1.4% of Nanovibronix shares are held by insiders. Comparatively, 1.5% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Lifeward has a net margin of -123.66% compared to Nanovibronix's net margin of -923.20%. Nanovibronix's return on equity of -54.25% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-923.20%	-54.25%	-43.10%
Lifeward	-123.66%	-243.14%	-97.39%

Lifeward has a consensus target price of $10.00, suggesting a potential upside of 43.64%. Given Lifeward's stronger consensus rating and higher possible upside, analysts clearly believe Lifeward is more favorable than Nanovibronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lifeward	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, Nanovibronix had 1 more articles in the media than Lifeward. MarketBeat recorded 3 mentions for Nanovibronix and 2 mentions for Lifeward. Lifeward's average media sentiment score of 1.33 beat Nanovibronix's score of 0.96 indicating that Lifeward is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nanovibronix	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lifeward	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nanovibronix has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market.

Nanovibronix has higher earnings, but lower revenue than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$2.18M	2.30	-$18.18M	-$8.82	N/A
Lifeward	$22.03M	0.89	-$19.91M	-$19.66	N/A

Summary

Nanovibronix and Lifeward tied by winning 8 of the 16 factors compared between the two stocks.

How does Nanovibronix compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Nanovibronix (NASDAQ:FEED) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment.

IRIDEX has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market. Comparatively, Nanovibronix has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market.

In the previous week, IRIDEX and IRIDEX both had 3 articles in the media. Nanovibronix's average media sentiment score of 0.96 beat IRIDEX's score of 0.87 indicating that Nanovibronix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nanovibronix	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IRIDEX has higher revenue and earnings than Nanovibronix. IRIDEX is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.38	-$4.44M	-$0.19	N/A
Nanovibronix	$2.18M	2.30	-$18.18M	-$8.82	N/A

IRIDEX currently has a consensus price target of $3.00, indicating a potential upside of 157.73%. Given IRIDEX's stronger consensus rating and higher probable upside, equities research analysts clearly believe IRIDEX is more favorable than Nanovibronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nanovibronix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Comparatively, 1.4% of Nanovibronix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

IRIDEX has a net margin of -6.23% compared to Nanovibronix's net margin of -923.20%. Nanovibronix's return on equity of -54.25% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
Nanovibronix	-923.20%	-54.25%	-43.10%

Summary

IRIDEX beats Nanovibronix on 10 of the 15 factors compared between the two stocks.

How does Nanovibronix compare to Retractable Technologies?

Nanovibronix (NASDAQ:FEED) and Retractable Technologies (NYSE:RVP) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Retractable Technologies has a net margin of -41.11% compared to Nanovibronix's net margin of -923.20%. Retractable Technologies' return on equity of -17.15% beat Nanovibronix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-923.20%	-54.25%	-43.10%
Retractable Technologies	-41.11%	-17.15%	-9.33%

In the previous week, Nanovibronix had 3 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Nanovibronix and 0 mentions for Retractable Technologies. Nanovibronix's average media sentiment score of 0.96 beat Retractable Technologies' score of 0.00 indicating that Nanovibronix is being referred to more favorably in the media.

Company	Overall Sentiment
Nanovibronix	Positive
Retractable Technologies	Neutral

Retractable Technologies has higher revenue and earnings than Nanovibronix. Retractable Technologies is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$2.18M	2.30	-$18.18M	-$8.82	N/A
Retractable Technologies	$37.15M	0.55	-$7.01M	-$0.21	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 1.4% of Nanovibronix shares are held by insiders. Comparatively, 59.5% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Nanovibronix has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market.

Summary

Nanovibronix and Retractable Technologies tied by winning 7 of the 14 factors compared between the two stocks.

How does Nanovibronix compare to Vyome?

Nanovibronix (NASDAQ:FEED) and Vyome (NASDAQ:HIND) are both small-cap manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

16.4% of Nanovibronix shares are owned by institutional investors. Comparatively, 22.1% of Vyome shares are owned by institutional investors. 1.4% of Nanovibronix shares are owned by insiders. Comparatively, 33.0% of Vyome shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Nanovibronix has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market. Comparatively, Vyome has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market.

Vyome has a net margin of -270.58% compared to Nanovibronix's net margin of -923.20%. Nanovibronix's return on equity of -54.25% beat Vyome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-923.20%	-54.25%	-43.10%
Vyome	-270.58%	-203.92%	-134.16%

Vyome has a consensus price target of $15.00, suggesting a potential upside of 563.72%. Given Vyome's stronger consensus rating and higher probable upside, analysts clearly believe Vyome is more favorable than Nanovibronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Nanovibronix and Nanovibronix both had 3 articles in the media. Vyome's average media sentiment score of 1.28 beat Nanovibronix's score of 0.96 indicating that Vyome is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nanovibronix	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Vyome	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Vyome has lower revenue, but higher earnings than Nanovibronix. Vyome is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$2.18M	2.30	-$18.18M	-$8.82	N/A
Vyome	$152.72K	103.85	-$10.26M	-$12.27	N/A

Summary

Vyome beats Nanovibronix on 9 of the 15 factors compared between the two stocks.

How does Nanovibronix compare to OSR?

OSR (NASDAQ:OSRH) and Nanovibronix (NASDAQ:FEED) are both small-cap manufacturing companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

55.3% of OSR shares are owned by institutional investors. Comparatively, 16.4% of Nanovibronix shares are owned by institutional investors. 36.8% of OSR shares are owned by company insiders. Comparatively, 1.4% of Nanovibronix shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Nanovibronix has lower revenue, but higher earnings than OSR. OSR is trading at a lower price-to-earnings ratio than Nanovibronix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.63M	5.06	-$27.06M	-$0.33	N/A
Nanovibronix	$2.18M	2.30	-$18.18M	-$8.82	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nanovibronix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

OSR has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Nanovibronix has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

In the previous week, Nanovibronix had 1 more articles in the media than OSR. MarketBeat recorded 3 mentions for Nanovibronix and 2 mentions for OSR. Nanovibronix's average media sentiment score of 0.96 beat OSR's score of 0.93 indicating that Nanovibronix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OSR	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nanovibronix	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OSR has a net margin of -363.26% compared to Nanovibronix's net margin of -923.20%. OSR's return on equity of -7.24% beat Nanovibronix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
Nanovibronix	-923.20%	-54.25%	-43.10%

Summary

OSR beats Nanovibronix on 8 of the 13 factors compared between the two stocks.

Get Nanovibronix News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FEED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FEED vs. The Competition

Export

Metric	Nanovibronix	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$5.01M	$2.83B	$4.34B	$12.37B
Dividend Yield	N/A	N/A	10.25%	5.66%
P/E Ratio	-0.09	13.72	22.29	24.65
Price / Sales	2.30	71.55	127.68	167.03
Price / Cash	N/A	8.03	40.19	37.92
Price / Book	0.03	6.75	26.12	6.81
Net Income	-$18.18M	$7.39M	$116.61M	$337.32M
7 Day Performance	4.04%	0.65%	1.84%	2.37%
1 Month Performance	-24.93%	-1.87%	1.77%	4.25%
1 Year Performance	N/A	12.97%	15.29%	32.60%

Nanovibronix Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FEED Nanovibronix	1.1069 of 5 stars	$0.82 -0.9%	N/A	N/A	$5.01M	$2.18M	N/A	20	Short Interest Decrease
LFWD Lifeward	3.084 of 5 stars	$7.28 -5.2%	$10.00 +37.4%	-48.6%	$21.61M	$22.03M	N/A	60	Positive News Gap Up
IRIX IRIDEX	2.3977 of 5 stars	$1.16 -1.3%	$3.00 +159.7%	+19.1%	$20.37M	$52.67M	N/A	120	Positive News
RVP Retractable Technologies	N/A	$0.66 -1.5%	N/A	+7.5%	$19.68M	$37.15M	N/A	240
HIND Vyome	3.5192 of 5 stars	$2.26 -1.7%	$15.00 +563.7%	N/A	$16.14M	$320K	N/A	50	News Coverage Positive News Short Interest Decrease Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FEED) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nanovibronix (FEED) Competitors

FEED vs. LFWD, IRIX, RVP, HIND, and OSRH

How does Nanovibronix compare to Lifeward?

Summary

How does Nanovibronix compare to IRIDEX?

Summary

How does Nanovibronix compare to Retractable Technologies?

Summary

How does Nanovibronix compare to Vyome?

Summary

How does Nanovibronix compare to OSR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEED vs. The Competition

Nanovibronix Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nanovibronix (FEED) Competitors

FEED vs. LFWD, IRIX, RVP, HIND, and OSRH

How does Nanovibronix compare to Lifeward?

Do institutionals & insiders hold more shares of FEED or LFWD?

Is FEED or LFWD more profitable?

Do analysts rate FEED or LFWD?

Does the media prefer FEED or LFWD?

Which has more risk and volatility, FEED or LFWD?

Which has better earnings & valuation, FEED or LFWD?

Summary

How does Nanovibronix compare to IRIDEX?

Which has more volatility & risk, IRIX or FEED?

Does the media refer more to IRIX or FEED?

Which has higher earnings and valuation, IRIX or FEED?

Do analysts rate IRIX or FEED?

Do institutionals & insiders have more ownership in IRIX or FEED?

Is IRIX or FEED more profitable?

Summary

How does Nanovibronix compare to Retractable Technologies?

Is FEED or RVP more profitable?

Does the media prefer FEED or RVP?

Which has better earnings and valuation, FEED or RVP?

Do analysts prefer FEED or RVP?

Do insiders and institutionals hold more shares of FEED or RVP?

Which has more risk and volatility, FEED or RVP?

Summary

How does Nanovibronix compare to Vyome?

Do institutionals and insiders hold more shares of FEED or HIND?

Which has more risk & volatility, FEED or HIND?

Is FEED or HIND more profitable?

Do analysts rate FEED or HIND?

Does the media prefer FEED or HIND?

Which has stronger earnings and valuation, FEED or HIND?

Summary

How does Nanovibronix compare to OSR?

Do institutionals and insiders have more ownership in OSRH or FEED?

Which has stronger valuation & earnings, OSRH or FEED?

Do analysts prefer OSRH or FEED?

Which has more volatility & risk, OSRH or FEED?

Does the media favor OSRH or FEED?

Is OSRH or FEED more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEED vs. The Competition

Nanovibronix Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools